INSIGHT. A new generation of predictive health is emerging at the intersection of artificial intelligence and life science. Researchers at the European Molecular Biology Laboratory (EMBL), the German Cancer Research Centre (DKFZ) and the University of Copenhagen have developed Delphi-2M, a generative AI model that predicts the risk of developing
INSIGHT. Crossing the blood-brain barrier has long been one of the greatest challenges in drug development. Now we’re seeing technological breakthroughs that open the door for new treatments of neurodegenerative diseases, an area with great medical need and growing investment interest. A smart protection, but also a barrier to treatment
PRESS RELEASE. Sciety has strengthened the board of its portfolio company PeptiSystems by appointing Nick Roelofs – a strategic addition that significantly enhances the company’s ability to scale global sales and build strong industrial partnerships within advanced pharmaceutical manufacturing. The appointment is part of Sciety’s broader strategy to actively contribute specialist
PRESS RELEASE. Sciety’s portfolio company Pharmability (fd TIRmed) has strengthened its board with the appointment of Peder Walberg – a strategic addition as the company advances the development of a promising new treatment for atopic dermatitis (eczema). The appointment is the result of a targeted recruitment process carried out in close
INSIGHT. Cardiac arrest can strike anyone, at any time – and every minute is crucial for survival. Although early cardiopulmonary resuscitation (CPR) and defibrillation can dramatically increase the chances of survival, mortality rates remain high. Let us take a closer look at proven methods that save lives, as well as new
INSIGHT. The life science sector is evolving rapidly and remains an attractive field for investors. New technologies are enabling treatments, diagnostics, and medical devices that were once unimaginable. Scientific breakthroughs and innovative companies are driving the industry forward. But as an investor, how can you identify the most promising companies to invest